Clinician characteristics associated with fluoride varnish applications during well-child visits

Am J Manag Care. 2024 Jul 1;30(7):e203-e209. doi: 10.37765/ajmc.2024.89582.

Abstract

Objectives: To identify factors associated with clinicians' likelihood and intensity of applying fluoride varnish (FV) overall and for visits paid by Medicaid and private insurers.

Study design: Observational study using claims data.

Methods: Using the Massachusetts All-Payer Claims Database (2016-2018), we conducted a repeated cross-sectional study of 2911 clinicians (7277 clinician-year observations) providing well-child visits to children aged 1 to 5 years. Zero-inflated negative binomial models estimated the probability of a clinician applying FV and the number of visits with FV applications, overall and separately for visits paid by Medicaid and private insurers.

Results: A total of 30.9% of clinician-years applied FV at least once, and overall, an average of 8.4% of a clinician's well-child visits included FV annually. Controlling for all covariates, having a higher percentage of patients insured by Medicaid was associated with applying FV (OR, 1.35; 95% CI, 1.23-1.45) and a higher expected number of applications (OR, 1.05; 95% CI, 1.02-1.09). Additionally, having a higher percentage of patients aged 1 to 5 years was associated with applying FV (OR, 1.20; 95% CI, 1.01-1.43), but not the number of applications. Similar associations were observed among visits paid by private insurers.

Conclusions: Despite clinical recommendations and mandated insurance reimbursements, the likelihood and intensity of FV applications was low for most pediatric primary care clinicians. Clinician behavior was associated with patient-panel characteristics, suggesting the need for interventions that account for these differences.

Publication types

  • Observational Study
  • Research Support, N.I.H., Extramural

MeSH terms

  • Child, Preschool
  • Cross-Sectional Studies
  • Female
  • Fluorides, Topical* / administration & dosage
  • Fluorides, Topical* / therapeutic use
  • Humans
  • Infant
  • Insurance Claim Review
  • Insurance, Health / statistics & numerical data
  • Male
  • Massachusetts
  • Medicaid* / statistics & numerical data
  • Practice Patterns, Physicians' / statistics & numerical data
  • United States

Substances

  • Fluorides, Topical